RXRX vs TDOC

Comparison between Recursion Pharmaceuticals Inc - Class A (RXRX, Company) and Teladoc Health Inc (TDOC, Company).

Both RXRX and TDOC are from the Healthcare sector.

5-Year PerformanceRXRX has outperformed TDOC, delivering a return of -38.8% compared to -42.4%

RXRX vs TDOC - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	RXRX(COMPANY)	TDOC(COMPANY)
Market Cap	$1.76B	$1.75B
Max Drawdown	93.13%	98.48%
Sharpe Ratio	-0.61	0.54
5Y Beta	2.63	1.40
Industry	Biotechnology	Health Information Services
P/E Ratio	-2.87	-10.14
Forward P/E	N/A	303.03
PEG Ratio	N/A	-1.01
5Y EPS CAGR	-10.03%	-21.04%
Debt to Equity	0.00%	0.00%
Free Cash Flow Yield	-18.55%	15.97%
P/S Ratio	26.45	0.67
P/B Ratio	1.73	1.30

Market Cap

Winner

RXRX

$1.76B

TDOC

$1.75B

Max Drawdown

Winner

RXRX

93.13%

TDOC

98.48%

Sharpe Ratio

RXRX

-0.61

Winner

TDOC

0.54

5Y Beta

RXRX

2.63

Winner

TDOC

1.40

Industry

RXRX

Biotechnology

TDOC

Health Information Services

P/E Ratio

RXRX

-2.87

Winner

TDOC

-10.14

Forward P/E

RXRX

N/A

TDOC

303.03

PEG Ratio

RXRX

N/A

TDOC

-1.01

5Y EPS CAGR

Winner

RXRX

-10.03%

TDOC

-21.04%

Debt to Equity

RXRX

0.00%

TDOC

0.00%

Free Cash Flow Yield

RXRX

-18.55%

Winner

TDOC

15.97%

P/S Ratio

RXRX

26.45

Winner

TDOC

0.67

P/B Ratio

RXRX

1.73

Winner

TDOC

1.30

RXRX vs TDOC - Historical Returns

Returns include dividend reinvestment.

Period	RXRX	TDOC
1 month	-3.14%	+28.10%
3 months	-13.48%	+61.83%
6 months	-33.19%	+57.63%
1 year	-51.88%	+16.57%
5 years(CAGR)	-38.84%	-42.42%
10 years(CAGR)	N/A	-5.39%
Max(CAGR)	-35.64%	-9.28%

RXRX

-3.14%

Winner

TDOC

+28.10%

RXRX

-13.48%

Winner

TDOC

+61.83%

RXRX

-33.19%

Winner

TDOC

+57.63%

RXRX

-51.88%

Winner

TDOC

+16.57%

5Y(CAGR)

Winner

RXRX

-38.84%

TDOC

-42.42%

10Y(CAGR)

RXRX

N/A

TDOC

-5.39%

Max(CAGR)

RXRX

-35.64%

Winner

TDOC

-9.28%

RXRX vs TDOC - Annual Returns (2015 - 2026)

Returns include dividend reinvestment.

Year	RXRX	TDOC
2026	-26.67%	+37.73%
2025	-43.27%	-26.47%
2024	-31.51%	-58.55%
2023	+30.60%	-4.56%
2022	-57.24%	-75.13%
2021	-45.27%	-54.23%
2020	N/A	+140.16%
2019	N/A	+73.77%
2018	N/A	+36.93%
2017	N/A	+111.21%
2016	N/A	-8.28%
2015	N/A	-36.98%

RXRX vs TDOC Drawdown Comparison

The maximum drawdown for RXRX was -93.13%, occurring on Mar 30, 2026. This drawdown has not yet recovered.

The maximum drawdown for TDOC was -98.48%, occurring on Feb 12, 2026. This drawdown has not yet recovered.

The current RXRX drawdown is -92.55%. The current TDOC drawdown is -96.70%.

Rank	RXRX	TDOC
#1	-93.13% Jul 13, 2021 - Mar 30, 2026	-98.48% Feb 8, 2021 - Feb 12, 2026
#2	-38.10% Apr 29, 2021 - Jun 17, 2021	-72.72% Aug 4, 2015 - Jun 19, 2017
#3	-10.54% Apr 16, 2021 - Apr 21, 2021	-50.34% Sep 28, 2018 - Jan 6, 2020
#4	-10.45% Jun 21, 2021 - Jul 6, 2021	-30.86% Aug 4, 2020 - Jan 22, 2021
#5	-8.29% Apr 21, 2021 - Apr 29, 2021	-24.19% Sep 14, 2017 - Nov 30, 2017
#6	N/A	-20.08% Mar 10, 2020 - Mar 23, 2020
#7	N/A	-19.92% Jun 28, 2017 - Sep 14, 2017
#8	N/A	-19.36% Apr 27, 2020 - Jun 19, 2020
#9	N/A	-16.93% Mar 23, 2020 - Apr 15, 2020
#10	N/A	-16.53% Jan 5, 2018 - Feb 20, 2018
#11	N/A	-15.09% Nov 30, 2017 - Jan 4, 2018
#12	N/A	-14.99% Jul 19, 2018 - Aug 10, 2018
#13	N/A	-12.60% Mar 7, 2018 - May 2, 2018
#14	N/A	-10.67% Jun 20, 2018 - Jul 5, 2018
#15	N/A	-8.80% Jun 19, 2017 - Jun 23, 2017